Quick tutorial I made on how to increase your brightness in Minecraft Java edition without mods or shaders. Science says ...

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the ...

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the ...

Last week, you might have seen that TerrAscend Corp. (TSE:TSND) released its quarterly result to the market. The early response was not positive, with shares down 4.0% to CA$0.95 in the past week.

Kanan, Corbin, Schupak & Aronow, Inc. Thank you, operator, and good morning. Welcome to the TerrAscend Third Quarter 2025 Financial Results Conference Call. Joining us for today's call are Jason Wild, ...

Terrascend (TSND) Earnings Dates & Reports On this page, you can find detailed information about the financial performance of Terrascend Corp, including the latest Terrascend Corp earnings report and ...

TerrAscend operates in the Canadian cannabis sector, showing notable growth. The stock has experienced long-term declines despite recent quarterly improvements. Market focus appears to be on expansion ...

TerrAscend Corp. (TSE:TSND) shareholders will doubtless be very grateful to see the share price up 130% in the last quarter. But will that heal all the wounds inflicted over 5 years of declines?

TerrAscend’s (TSX:TSND:CA) has renewed its normal course issuer bid to repurchase up to $10M worth of common shares over a 12-month period starting August 22, 2025. The buyback allows for repurchase ...

Trailing total returns as of 2025-08-15, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) Return TSND.TO S&P/TSX Composite index (^GSPTSE) ...

NEW YORK, July 10, 2025 /PRNewswire/ -- Transcend Therapeutics, a clinical-stage biotechnology company that develops medicines to treat neuropsychiatric diseases, today announced that the U.S. Food & ...